Skip to content

Improve Clinical Trial Accrual Rates with Precision Decision

The world of precision medicine continues to evolve, making it increasingly difficult to stay on top of the latest developments and treatments available. GenomOncology’s newest solution, Precision Decision, is designed to reduce this effort associated with identifying and analyzing relevant, up-to-date clinical trials and therapy options for patient treatment. 

 Watch the on-demand demo of Precision Decision today to learn how this product streamlines the matching of patients to relevant, open clinical trials and therapies in order to improve overall patient care. 

 

Featured Presenter

James Cole has over a decade of experience in precision oncology, making him integral in GenomOncology's understanding of the field of clinical genomics. Cole works across GenomOncology’s Precision Oncology Platform (POP), ensuring all our precision oncology solutions include the necessary precision oncology data sets in order to inform decision support and streamline patient treatment analysis and research.

James Cole, PhD

James Cole, PhD
Vice President of Product Innovation